Genomics of Peritoneal Malignancies

Enusha Karunasena, Jonathan Sham, Kevin Wyatt McMahon, Nita Ahuja

Research output: Contribution to journalReview article

Abstract

The peritoneum protects the intraabdominal organs. This function is exploited by aggressive cancers originating from organs within the abdomen, resulting in peritoneal metastasis. We discuss genomic variants that may lead to peritoneal metastasis from multiple cancers. Peritoneal malignancies are attributed to epithelial-mesenchymal transition. These metastatic lesions harbor similar genetic mutations to the primary tumor yet may manifest clone-specific aberrations that promote propagation. Peritoneal metastasis are increasingly being treated with surgical resection as an adjunct to radiation, chemotherapy, and other biologic therapies. We describe genetic and genomic variances that are predictive markers for metastasis and burgeoning indicators for peritoneal malignancies.

Original languageEnglish (US)
Pages (from-to)463-475
Number of pages13
JournalSurgical Oncology Clinics of North America
Volume27
Issue number3
DOIs
StatePublished - Jul 1 2018

Fingerprint

Genomics
Neoplasm Metastasis
Neoplasms
Biological Therapy
Epithelial-Mesenchymal Transition
Peritoneum
Abdomen
Clone Cells
Radiation
Drug Therapy
Mutation

Keywords

  • Colorectal
  • Epigenetics
  • Genomics
  • Microarray
  • Mutations
  • Ovarian
  • Pancreatic
  • Sequencing

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Genomics of Peritoneal Malignancies. / Karunasena, Enusha; Sham, Jonathan; McMahon, Kevin Wyatt; Ahuja, Nita.

In: Surgical Oncology Clinics of North America, Vol. 27, No. 3, 01.07.2018, p. 463-475.

Research output: Contribution to journalReview article

Karunasena, Enusha ; Sham, Jonathan ; McMahon, Kevin Wyatt ; Ahuja, Nita. / Genomics of Peritoneal Malignancies. In: Surgical Oncology Clinics of North America. 2018 ; Vol. 27, No. 3. pp. 463-475.
@article{2a3ecd729b1041948c522dc8257b67ba,
title = "Genomics of Peritoneal Malignancies",
abstract = "The peritoneum protects the intraabdominal organs. This function is exploited by aggressive cancers originating from organs within the abdomen, resulting in peritoneal metastasis. We discuss genomic variants that may lead to peritoneal metastasis from multiple cancers. Peritoneal malignancies are attributed to epithelial-mesenchymal transition. These metastatic lesions harbor similar genetic mutations to the primary tumor yet may manifest clone-specific aberrations that promote propagation. Peritoneal metastasis are increasingly being treated with surgical resection as an adjunct to radiation, chemotherapy, and other biologic therapies. We describe genetic and genomic variances that are predictive markers for metastasis and burgeoning indicators for peritoneal malignancies.",
keywords = "Colorectal, Epigenetics, Genomics, Microarray, Mutations, Ovarian, Pancreatic, Sequencing",
author = "Enusha Karunasena and Jonathan Sham and McMahon, {Kevin Wyatt} and Nita Ahuja",
year = "2018",
month = "7",
day = "1",
doi = "10.1016/j.soc.2018.02.004",
language = "English (US)",
volume = "27",
pages = "463--475",
journal = "Surgical Oncology Clinics of North America",
issn = "1055-3207",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Genomics of Peritoneal Malignancies

AU - Karunasena, Enusha

AU - Sham, Jonathan

AU - McMahon, Kevin Wyatt

AU - Ahuja, Nita

PY - 2018/7/1

Y1 - 2018/7/1

N2 - The peritoneum protects the intraabdominal organs. This function is exploited by aggressive cancers originating from organs within the abdomen, resulting in peritoneal metastasis. We discuss genomic variants that may lead to peritoneal metastasis from multiple cancers. Peritoneal malignancies are attributed to epithelial-mesenchymal transition. These metastatic lesions harbor similar genetic mutations to the primary tumor yet may manifest clone-specific aberrations that promote propagation. Peritoneal metastasis are increasingly being treated with surgical resection as an adjunct to radiation, chemotherapy, and other biologic therapies. We describe genetic and genomic variances that are predictive markers for metastasis and burgeoning indicators for peritoneal malignancies.

AB - The peritoneum protects the intraabdominal organs. This function is exploited by aggressive cancers originating from organs within the abdomen, resulting in peritoneal metastasis. We discuss genomic variants that may lead to peritoneal metastasis from multiple cancers. Peritoneal malignancies are attributed to epithelial-mesenchymal transition. These metastatic lesions harbor similar genetic mutations to the primary tumor yet may manifest clone-specific aberrations that promote propagation. Peritoneal metastasis are increasingly being treated with surgical resection as an adjunct to radiation, chemotherapy, and other biologic therapies. We describe genetic and genomic variances that are predictive markers for metastasis and burgeoning indicators for peritoneal malignancies.

KW - Colorectal

KW - Epigenetics

KW - Genomics

KW - Microarray

KW - Mutations

KW - Ovarian

KW - Pancreatic

KW - Sequencing

UR - http://www.scopus.com/inward/record.url?scp=85048723442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048723442&partnerID=8YFLogxK

U2 - 10.1016/j.soc.2018.02.004

DO - 10.1016/j.soc.2018.02.004

M3 - Review article

C2 - 29935683

AN - SCOPUS:85048723442

VL - 27

SP - 463

EP - 475

JO - Surgical Oncology Clinics of North America

JF - Surgical Oncology Clinics of North America

SN - 1055-3207

IS - 3

ER -